A database of 660 peptide ion cross sections: use of intrinsic size parameters for bona fide predictions of cross sections  by Valentine, Stephen J. et al.
A Database of 660 Peptide Ion Cross Sections:
Use of Intrinsic Size Parameters for Bona Fide
Predictions of Cross Sections
Stephen J. Valentine, Anne E. Counterman, and David E. Clemmer
Department of Chemistry, Indiana University, Bloomington, Indiana, USA
An ion trap/ion mobility/time-of-flight mass spectrometry technique has been used to
measure collision cross sections for 660 peptide ions generated by tryptic digestion of 34
common proteins. Measured cross sections have been compiled into a database that contains
peptide molecular weight and sequence information. The database is used to generate average
intrinsic contributions to cross section (size parameters) for different amino acid residues by
solving systems of equations that relate the unknown contributions of individual residues to
the sequences and cross sections of database peptides. Size parameters are combined with
information about amino acid composition to calculate cross sections for database peptides.
Bona fide cross section predictions (made prior to measurement) for peptides observed in
tryptic digests of sperm whale myoglobin and yeast enolase are made. Eight of 10 predicted
cross sections are within 2% of the experimental values and all 10 are within 3.2%. The utility
of size parameters for cross section prediction is explored and discussed. (J Am Soc Mass
Spectrom 1999, 10, 1188–1211) © 1999 American Society for Mass Spectrometry
Recently we have developed a hybrid electrosprayionization (ESI) [1]/ion trap [2, 3]/ion mobility[4]/time-of-flight mass spectrometry (TOFMS)
technique [5, 6] that allows mass-to-charge (m/z) ratios
of mobility-separated ions to be measured in a single
experimental sequence. The method is rapid, sensitive,
and especially suited for determination of average cross
sections [7] for components of mixtures, such as pep-
tides formed by tryptic digestion of proteins. In this
paper we report a database of cross sections and se-
quences for 660 singly and doubly charged peptide ions
obtained from tryptic digestion of common proteins.
Prior to measurement of this database, cross sections of
only a few dozen peptides were reported [6, 8–10].
Cross sections provide information about the three-
dimensional structures of ions; a collection of these
measurements should benefit efforts to understand the
intrinsic structural properties of peptides in the absence
of sovent.
In an initial report, we used 113 cross sections for
singly-protonated peptides having the general form
[XxxnLys 1 H]
1 (Xxx refers to any naturally occurring
amino acid except Cys, His, Lys, or Arg and n 5 4 –9)
to derive information about the intrinsic sizes of amino
acids [11]. This was accomplished by writing a system
of 113 equations that relates the occurrence frequency
and unknown amino acid sizes (17 in this study) to a








In this equation, nij corresponds to the number of times
an amino acid i occurs in each sequence j, Vj,reduced is
the reduced cross section of sequence j (described
below), and pi is the unknown amino acid size param-
eter. The 113 equations were solved for the average,
best-fit intrinsic size parameters (pi) using a linear
algebra regression method described previously [12].
Size parameters were subsequently combined with pep-
tide sequences in order to calculate cross sections for the
113 peptides. More than 90% of the calculated cross
sections were within 2% of experiment [11].
There are three objectives in the work presented
here: (1) to report the measured cross sections; (2) to
examine the utility of intrinsic size parameters for cross
section predictions; and (3) to begin to assess the utility
of size parameters as structural indicators. This report is
primarily aimed at simply making these values avail-
able. A consideration in the decision to report an
extensive list of tryptic digest peptides is that peptide
sequences reflect those associated with elements of
structure relevant to proteins. One use of this database
may be to restrict structures for gas-phase ions gener-
ated by molecular modeling methods. We have recently
used this approach to derive volumes for individual
amino acids in peptide ions and compare these values
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with those found in protein cores [13]. Because peptides
are derived from common proteins, it is often possible
to compare model structures of the gas-phase peptide
ion sequences to the structures of identical sequences
within the anteceding protein core. The data should be
directly useful for calculation of collision frequencies
during ion formation and the transient time that ions
exist in various mass spectrometers.
Insomuch as it is possible, the accomplishment of the
second goal—to predict peptide cross sections from
sequence—would have a significant impact on the
ability to assign peaks in nested ion mobility/time-of-
flight mass spectra. The combination of accurate m/z
measurements and calculated cross sections (for ex-
pected peptide sequences) may provide a viable alter-
native to fragmentation-based strategies for peak as-
signments in spectra of complicated mixtures (e.g.,
peptides from digestion of protein mixtures). The mo-
bility separation is an interesting time regime (millisec-
onds), which is intermediate between the microsecond
flight times required for m/z determination and sec-
onds-to-minutes timescales for condensed phase sepa-
rations. Our laboratory is currently interfacing a con-
densed phase separation strategy with the ion
mobility/time-of-flight approach; the data presented
here are important in the foundation associated with
developing these methods.
Predictions of cross section from sequences would
also help define gas-phase ion structures. In the small
systems reported here, it appears that structure is
largely determined by composition instead of sequence
[11]; some dramatic examples, in which position of a
charged residue is used to stabilize and destabilize
helices, have been presented [10a]. Here, we find that
the number of calculated cross sections within 2% of
experimental data can be remarkably high (;70%–90%
for different regions of the database). Further improve-
ments in accuracy are expected if sequence constraints
are added; however, none have been used in this report.
Calculations of cross sections for peptides that were
used to derive the intrinsic size parameters (i.e., retro-
dictions) [14] are more accurate than calculations for
regions not contained in the parameterization set. Pep-
tide length appears to be an important factor that limits
the application of parameters for cross section predic-
tion. Below we provide several parameter sets that
should be useful for calculating cross sections for pep-
tides containing 3–15 residues. We also report bona fide
predictions of cross section (predictions made prior to
measurement) [14]. In these predictions, 8 of 10 cross
sections that were predicted for small [XxxnLys 1 H]
1
peptides (n 5 4 to 9) were within 2% of experimental
values; all 10 calculated cross sections were within 3.2%.
The third goal of this work—assessment of intrinsic
size factors as structural indicators—is more challeng-
ing. Intrinsic size parameters, determined directly from
experimental data, arise from a combination of factors
including the average contributions of residues to the
physical shapes of the peptides, as well as differences in
the collision dynamics associated with interaction of the
buffer gas with different residues. As we discuss below,
a parameter derived for an individual residue (within a
parameter set) can vary substantially, depending upon
the behavior of other residues; at this stage, even the
relatively large database allows only very limited ex-
ploration of how parameters vary with length, se-
quence, and conformer type. However, we begin this
assessment here and note that in future work we will
expand this database. This should help clarify the
meaning of size parameters.
A number of other methods are being developed to
investigate the conformations of anhydrous biomolecu-
lar ions. Hydrogen–deuterium exchange [15], proton-
transfer [16], and molecular adduction experiments [17]
provide structural information based on differences in
the chemical properties of specific conformations. Ki-
netic energy release measurements [18], microscopy
studies of high-energy impacts of proteins on surfaces
[19], and collision cross section measurements utilizing
ion scattering [20, 21] and ion mobility [8, 9, 22, 23]
methods yield information about the physical sizes of
the gas-phase biomolecules. These experimental meth-
ods have been complemented by molecular modeling
techniques to provide insight into gas-phase conforma-
tions [8, 24, 25]. The work presented here is also related
to condensed-phase studies involving structural predic-
tion based on sequence information [14, 26, 27].
Experimental
Overview
The ESI/ion trap/ion mobility/mass spectrometry
methods used here have been discussed previously [3,
5, 6]; a brief description is presented here. The contin-
uous electrospray ion beam is accumulated for ;100 ms
in an ion trap. Concentrated ion packets are injected
into a 40.4 cm long drift tube containing ;2–3 torr of
helium buffer gas at 300 K. Ions travel across the drift
tube under the influence of an attractive uniform elec-
tric field (8.66 V cm21) that is established by a series of
evenly spaced BeCu rings. As ions drift through the
buffer gas they are separated based on differences in
their mobilities; compact ions have higher mobilities
than elongated ones. After exiting the drift tube, ions
are focussed into the source region of a time-of-flight
(TOF) mass spectrometer where high-voltage, high-
frequency pulses (synchronous with the initial ion-
mobility injection pulse) are used to initiate time-of-
flight measurements.
Formation of Mixtures of Peptide Ions
Information about the purities and sources for proteins
used in tryptic digestion is provided in Tables 1 and 2.
Tryptic fragments for each protein are generated by
combining 150 mL of a 0.2 mg/mL trypsin (Sigma,
sequencing grade) solution in 0.2 M ammonium bicar-
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Table 1. Cross sections for singly protonated peptides from tryptic digestsa
Number
of residues Assigned sequenceb Peptide sourcec MWd Cross section (Å2)e
Number of
measurementsf
2 AK gludehy_bov 217.28 87.01 1
2 AR lactotrans_bov 245.29 93.79 1
2 EK albu_pig 275.31 97.89 (1.14) 9
alcodehy_yst
BSA
2 ER albu_dog 303.33 102.02 (0.65) 6
albu_horse
2 FK albu_pig 293.37 101.74 (1.00) 3
HSA
2 FR canhyd_bov 321.39 111.10 (0.03) 2
2 HK cytc_horse 283.30 98.96 (0.76) 6
bcas_bov
crephos_rab
2 IR conalb_chick 287.37 106.73 1
2 KK canhyd_bov 274.37 97.40 (0.60) 3
cytc_horse














2 NR canhyd_bov 288.31 101.76 (1.49) 5
gludehy_bov
lys_tew
2 QR albu_pig 302.34 104.07 (1.92) 7
albu_sheep
BSA
2 RP transfr_hum 271.33 96.48 (2.22) 2
2 SK aldol_rab 233.27 88.57 1
2 TK blacto_bov 247.30 92.76 (0.86) 2
2 TR gludehy_bov 275.32 100.59 (1.09) 3





2 VR conalb_chick 273.34 104.93 (2.94) 3





2 YK crephos_rab 309.37 104.66 (2.10) 4
HSA





3 ADR transfr_hum 360.38 123.31 (0.68) 2
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Table 1. (Continued)
Number
of residues Assigned sequenceb Peptide sourcec MWd Cross section (Å2)e
Number of
measurementsf
3 ALK alcodehy_yst 330.43 116.85 (1.95) 4
blacto_bov
3 APR lactotrans_bov 342.4 113.05 (1.78) 3
3 ATK HSA 318.38 103.25 1
3 AVK albu_horse 316.41 110.53 (0.76) 3
3 CEK kcas_bov 378.45 124.58 1
3 CRR lactotrans_bov 433.54 137.86 (0.38) 2
3 DER kcas_bov 418.41 123.18 (3.30) 3
3 EFK albu_horse 422.49 134.38 (0.88) 3
3 FDK blacto_bov 408.46 127.82 (0.54) 2
3 FGK lactotrans_bov 350.43 116.66 (1.41) 2
3 FPK albu_pig 390.49 123.14 (0.85) 8
albu_sheep
BSA
3 FYR aldol_rab 484.56 147.93 (1.34) 3
3 GER crephos_rab 360.38 116.82 (0.34) 3
3 GKK cytc_horse 331.40 111.71 (1.19) 3
3 GWK alcodehy_yst 389.46 123.70 (1.18) 3
3 HFK albu_horse 430.51 133.96 (1.01) 3
3 HLK myo_horse 396.50 133.05 (0.71) 2
3 HPK crephos_rab 380.45 123.77 (2.63) 3
3 IAK albu_horse 330.43 113.56 (1.50) 6
kcas_bov
3 IEK bcas_bov 388.47 127.42 (0.54) 3
3 INK bcas_bov 373.46 122.09 (0.19) 3
3 ITK albu_horse 360.46 118.89 (1.19) 2
3 KLR crephos_rab 415.54 139.37 (1.45) 3
3 LAK albu_dog 330.43 118.08 (1.19) 5
enolase_yst
3 LFK myo_sw 406.53 130.29 1
3 LVK albu_sheep 358.49 127.00 (1.69) 3
3 MEK alcodehy_yst 406.50 126.51 (3.22) 2
3 NLR lactotrans_bov 401.47 132.47 (2.00) 6
transfr_hum
3 NYK albu_pig 423.48 133.47 (1.39) 2
3 QIK albu_horse 387.49 129.74 (1.13) 5
albu_sheep
BSA
3 QVR canhyd_bov 401.47 131.12 (1.87) 2
3 SIK crephos_rab 346.46 116.59 (0.35) 2
3 TGR crephos_rab 332.37 109.48 (2.51) 3
3 TVR transfr_hum 374.45 122.49 (0.85) 3
3 VHK albu_sheep 382.47 123.04 (1.57) 2
3 VTK albu_sheep 346.43 114.24 (0.79) 2




3 YTR albu_sheep 438.49 131.96 (0.97) 6
BSA
3 YVR alcodehy_yst 436.52 140.16 1
4 ADEK albu_sheep 461.48 138.92 (1.61) 4
BSA
4 ADTR alcodehy_yst 461.48 141.34 1
4 AGIK cytc_horse 387.50 130.20 (0.42) 2






4 ANVK hb_pig 430.51 136.46 (1.52) 3
(Continued)
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Table 1. (Continued)
Number
of residues Assigned sequenceb Peptide sourcec MWd Cross section (Å2)e
Number of
measurementsf
4 APPK conalb_chick 411.51 131.96 1
4 AQEK lactotrans_bov 474.50 141.97 (0.52) 2
4 ATNE cytc_horse 433.43 128.33 1
4 AVEK crephos_rab 445.52 141.29 (1.64) 3
4 AVLK canhyd_bov 429.57 145.63 (0.35) 2
4 AVSK enolase_yst 403.49 132.83 (1.99) 3
4 DAHK HSA 469.51 143.45 1
4 DLTK conalb_chick 475.55 147.56 (1.64) 3
4 DTHK albu_sheep 499.53 142.74 (1.62) 5
BSA
4 DTYK albu_pig 525.57 150.51 (1.36) 3
4 EAYK albu_dog 509.57 148.42 (0.47) 3
4 ENLK aldol_rab 502.58 150.35 (1.73) 2
4 EVFR crephos_rab 549.63 157.46 (2.83) 3
4 EVVR acas_bov 501.59 148.81 (0.11) 2
4 FGAK gludehy_bov 421.50 134.34 (0.96) 3
4 FGDR albu_dog 493.53 144.12 (0.44) 3
4 FGER albu_pig 507.55 148.17 (0.18) 3
4 FLGK albu_horse 463.58 152.63 (0.74) 3
4 FWGK albu_pig 536.64 160.46 (0.50) 8
albu_sheep
BSA
4 GFPK canhyd_bov 447.54 141.49 (0.20) 2
4 GGIR gludehy_bov 401.47 129.69 (0.50) 3
4 GHGK hb_hum 397.44 129.51 (1.12) 2
4 GILA albu_pig 372.47 123.99 (0.99) 2
4 GILR gludehy_bov 457.58 148.38 (0.66) 3
4 GLVK alcodehy_yst 415.54 141.97 (1.46) 3
4 GNVK hb_bov 416.49 134.17 (1.11) 3
4 GTDK apotransf_bov 419.44 128.01 1
4 GVFR enolase_yst 477.57 146.75 (0.83) 3
4 HKPK albu_horse 508.63 149.94 (2.10) 6
BSA
4 IPSK apotransf_bov 443.55 139.78 (1.80) 4
lactotrans_bov
4 KIEK bcas_bov 516.65 155.03 (0.24) 3
4 LEHK alcodehy_yst 525.61 154.49 1
4 LHDR transfr_hum 539.60 157.14 (0.75) 3
4 LLSK lactotrans_bov 459.59 155.26 (0.63) 3
4 LNYK crephos_rab 536.64 163.88 (1.09) 2
4 LSQK albu_horse 474.57 149.68 (1.08) 9
albu_sheep
BSA
4 LSQR albu_dog 502.58 154.85 (1.16) 9
albu_pig
HSA
4 LTFK gludehy_bov 507.64 161.05 (0.27) 3
4 MDAK transfr_hum 463.56 135.56 (0.42) 3
4 NFGK hb_bov 464.53 137.95 (0.76) 4
4 NLGK HSA 430.51 132.68 1
4 QIMR gludehy_bov 546.69 159.34 1
4 Ac-QRLK HSA 585.71 163.41 1
4 SETK lactotrans_bov 463.50 155.20 1
4 SLGK BSA 403.49 132.39 (1.82) 3
4 SLTK enolase_yst 447.54 143.99 (0.30) 3
4 SNVK hb_sheep 446.51 136.52 (0.23) 3
4 SPIK alcodehy_yst 443.55 136.08 (0.90) 3
4 TNIK hb_dog 474.57 144.91 (0.63) 5
hb_rab
4 TNVK hb_hum 460.54 141.41 (0.17) 3
4 VGTK albu_dog 403.49 131.69 (0.66) 3
(Continued)
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Table 1. (Continued)
Number
of residues Assigned sequenceb Peptide sourcec MWd Cross section (Å2)e
Number of
measurementsf
4 VGTR BSA 431.50 136.71 (2.06) 3
4 VYAR enolase_yst 507.60 157.06 (0.93) 3
4 WMGK enolase_yst 520.65 152.87 (0.55) 3
4 WQWR lactotrans_bov 674.77 176.44 (0.68) 3
4 YLHR gludehy_bov 587.69 171.66 (3.96) 2
4 YTKK HSA 538.65 155.28 1




5 ADLAK albu_dog 516.60 159.31 (1.06) 9
albu_sheep
BSA
5 AFDEK BSA 608.66 168.36 (0.44) 3
5 AIAEK lactotrans_bov 530.63 160.73 (1.84) 3
5 APNAK glox_aspgn 499.57 147.31 (0.98) 2
5 AWGGK aldol_rab 517.59 152.16 (2.53) 3
5 CLVEK transfr_hum 590.74 170.73 1
5 DIAAK myo_sw 516.60 155.37 (2.98) 3




5 FFSDK kcas_bov 642.72 172.73 (2.52) 3
5 Ac-GDVEK cytc_horse 588.62 163.18 (1.29) 2
5 GGNMK crephos_rab 505.60 147.44 (1.24) 2
5 GITWK cytc_horse 603.70 169.34 (0.58) 3
5 GTFAK hb_dog 522.61 153.97 (0.91) 9
hb_pig
hb_rab
5 HPEAK HSA 580.65 163.89 1
5 IDAMR albu_sheep 604.73 172.80 (0.75) 3
5 IEHLR albu_pig 666.79 181.70 (0.16) 3
5 IETMR BSA 648.78 181.29 (0.81) 3
5 IFLER gludehy_bov 676.82 191.86 (0.96) 3
5 IFVQK cytc_horse 633.80 181.96 (0.51) 3
5 IIAEK blacto_bov 572.71 172.54 (0.50) 3
5 KATNE cytc_horse 561.60 153.95 (0.28) 3
5 KFWGK BSA 664.81 185.85 1
5 KNQDK kcas_bov 631.69 168.54 (3.29) 3
5 KVYGR lys_tew 621.74 175.06 (2.80) 2
5 LDALK albu_horse 558.68 172.36 (1.48) 3
5 LDELR HSA 644.73 181.93 (0.96) 2
5 LHSMK acas_bov 614.77 169.24 (1.22) 2
5 LNELR apotransf_bov 643.75 182.27 (1.13) 3
5 NLNEK transfr_hum 616.68 167.97 (0.94) 3
5 NRQVR canhyd_bov 671.76 175.89 1
5 NTYEK transfr_hum 653.70 175.90 (2.66) 3
5 SVDGK lactotrans_bov 504.55 150.56 1
5 TAWEK hb_rab 633.71 170.03 (1.25) 3
5 TGQIK enolase_yst 545.64 157.62 (0.28) 3
5 TLTGK ubiq 518.62 157.34 (2.11) 2
5 TPGSK lys_tew 488.55 145.50 (1.17) 2
5 TVGGK apotransf_bov 460.54 140.18 (3.52) 2
5 VASLR BSA 544.66 163.70 (0.92) 3
5 VATLR albu_sheep 558.69 166.85 (0.49) 3
5 YYPLK crephos_rab 682.82 187.31 (0.38) 2
6 AAAAEK enolase_yst 559.63 160.38 (1.06) 2
6 AKIQDK ubiq 701.83 180.72 1
6 ALELFR myo_horse 747.90 202.99 (0.33) 3
6 ANIDVK enolase_yst 658.76 176.78 (0.76) 3
6 ASEDLK myo_sw 661.72 175.16 (0.58) 3
(Continued)
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Table 1. (Continued)
Number
of residues Assigned sequenceb Peptide sourcec MWd Cross section (Å2)e
Number of
measurementsf
6 AVGNLR transfr_hum 628.74 172.89 (0.27) 3




6 EAMAPK bcas_bov 645.78 176.19 (1.24) 2
6 EDLIAY cytc_horse 722.80 191.70 (0.29) 3
6 ELEDFK gludehy_bov 779.85 198.28 1
6 ELGFQG myo_horse 649.71 172.29 (0.14) 3
6 EMPFPK bcas_bov 747.91 193.26 (1.43) 3
6 FVIEIR albu_pig 775.95 207.16 (0.16) 3
6 GGVHVK crephos_rab 595.71 167.11 1
6 GQIVGR alcodehy_yst 628.74 173.63 (0.70) 3
6 GVPTKK glox_aspgn 628.78 178.28 (0.28) 2
6 HLDDLK hb_bov 739.83 193.90 (0.71) 7
hb_sheep
6 HLDNLK hb_pig 738.85 196.18 (1.17) 3
6 HPEAKR HSA 736.84 197.52 1
6 IEEIFK crephos_rab 777.92 197.00 (2.97) 3
6 ISATGR gludehy_bov 603.68 169.18 (0.75) 3
6 IVAPGK aldol_rab 583.74 173.33 (1.17) 3
6 LIFAGK ubiq 647.83 186.10 (1.58) 2
6 LNQLLR enolase_yst 755.92 204.97 (0.46) 3
6 LVEDLK gludehy_bov 715.85 192.17 (1.05) 2
6 MQIFVK ubiq 764.99 203.90 (0.59) 2
6 NDIAAK myo_horse 630.70 173.78 (0.84) 3
6 NLDNLK hb_dog 715.81 192.40 (0.69) 3
6 NVPLYK enolase_yst 732.89 195.27 (0.90) 3
6 NYAEAK HSA 694.75 181.87 1
6 NYQEAK albu_dog 751.80 191.16 (0.92) 8
albu_sheep
BSA
6 QCSTSK apotransf_bov 652.73 171.10 1
6 QLEDGR ubiq 716.76 186.94 1
6 QTIASN tryps 632.68 170.79 1






6 SEVAHR HSA 697.76 177.66 (2.46) 3
6 SGIQVR tryps 658.76 178.36 1
6 SKKTAK conA 661.81 168.94 1
6 SVYDSR enolase_yst 725.76 184.17 1
6 TEAEMK myo_horse 707.80 182.54 (2.25) 5
myo_sw
6 TGAPAR enolase_yst 571.64 162.57 (1.27) 3
6 TGPNLH cytc_horse 637.70 164.29 (0.30) 3
6 TPVSEK albu_horse 659.74 175.98 (0.73) 5
BSA
6 VKAHGK hb_dog 638.78 165.87 1
6 YDLDFK enolase_yst 799.89 201.01 1
6 YIPGTK cytc_horse 677.80 183.75 1
6 YLTTLK lactotrans_bov 737.90 197.94 (0.70) 3
7 AACLLPK HSA 714.93 194.76 1
7 AAGHDGK enolase_yst 654.69 170.18 (2.14) 2
7 ALPMHIR blacto_bov 837.06 213.70 (1.22) 3
7 APVDAFK lactotrans_bov 746.87 189.05 (0.76) 3
7 ASEDLKK myo_horse 789.89 196.81 (0.17) 3
7 ATDEQLK albu_sheep 803.87 205.89 (0.16) 2
7 ATEEQLK BSA 817.90 206.40 (1.81) 2
(Continued)
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Table 1. (Continued)
Number
of residues Assigned sequenceb Peptide sourcec MWd Cross section (Å2)e
Number of
measurementsf
7 AVPYPQR bcas_bov 829.96 202.81 (0.47) 2
7 DGADFAK aldol_rab 722.76 185.83 (0.90) 3
7 DSAIMLK conalb_chick 776.95 203.77 (1.32) 3
7 DTLQQER conalb_chick 888.94 206.76 (0.37) 3
7 ELTEFAK albu_sheep 836.95 209.40 (0.69) 2
7 EVTEFAK albu_pig 822.92 202.91 (0.29) 3
7 FGERAFK HSA 853.98 218.63 (1.78) 3
7 FNDLGEK albu_horse 821.89 206.73 (1.10) 3
7 GDVAFVK apotransf_bov 734.86 200.45 (1.77) 8
conalb_chick
transfr_hum
7 GFFYTPK ins_bov 859.00 221.88 1
7 GGVVGIK aldol_rab 628.78 175.87 (0.62) 3
7 GPFPIIV bcas_bov 741.94 195.69 (0.70) 3
7 GVLHAVK enolase_yst 722.89 198.60 (0.42) 3
7 HLADLSK enolase_yst 782.90 201.78 (0.62) 3
7 HNNHMAK crephos_rab 850.96 207.15 (4.31) 2
7 IATAIEK enolase_yst 744.89 202.92 (0.37) 3
7 ILLSSAK albu_horse 730.91 202.97 (0.75) 3
7 ISQRYQK acas_bov 922.06 225.85 1
7 IVTDLAK albu_pig 758.92 204.75 (1.40) 3
7 IVTDLTK albu_horse 788.95 207.02 (0.28) 3
7 LGLVGSR albu_pig 700.84 194.18 (0.27) 2
7 LMVEMEK crephos_rab 879.10 220.91 1
7 LSQRFPK HSA 875.05 225.29 (1.46) 2
7 LVTDLTK BSA 788.95 205.76 (0.98) 6
HSA
7 MIFAGIK cytc_horse 779.00 207.13 (0.39) 3
7 MLTAEEK hb_bov 820.96 209.77 (0.59) 6
hb_sheep
7 NPDPWAK transfr_hum 826.91 198.09 (0.38) 3
7 PIANGER canhyd_bov 755.84 201.77 1
7 Ac-SIPETQK alcodehy_yst 843.94 205.88 (1.31) 3
7 TFAEALR enolase_yst 806.92 209.98 (0.52) 3
7 VAAALTK hb_bov 672.83 190.32 (0.73) 7
hb_sheep
7 VADALTK hb_pig 716.84 194.69 (1.73) 3
7 VDPVNFK hb_dog 817.95 208.73 (0.91) 12
hb_bov
hb_hum
7 VLAAVYK aldol_rab 762.95 206.91 (1.08) 3
7 VLASSAR albu_sheep 702.82 195.27 (0.36) 3
7 VLPVPQK bcas_bov 779.99 206.94 (0.57) 3
7 VLSAADK hb_bov 702.81 193.03 (1.28) 10
hb_pig
hb_sheep
7 VLSPADK hb_dog 728.85 196.51 (1.02) 8
hb_hum
hb_rab
7 VLTSAAK albu_pig 688.83 194.37 (0.13) 3
7 VSEALTK hb_rab 746.87 198.59 (2.27) 3
7 VVTDLTK albu_dog 774.92 202.35 (0.99) 3
7 WNMQNGK conA 876.99 206.26 (0.19) 3
7 YLYEIAR albu_pig 927.08 228.03 (0.78) 6
BSA
HSA
7 YLYEVAR albu_horse 913.05 226.13 (0.63) 5
albu_sheep
8 AADALLLK enolase_yst 814.00 223.86 (2.78) 3
8 ADFAEISK albu_dog 879.97 218.06 (0.55) 3
8 ADFAEVSK albu_horse 865.95 214.17 (0.67) 3
8 ADFTDVTK albu_sheep 895.97 214.56 (1.13) 3
(Continued)
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of residues Assigned sequenceb Peptide sourcec MWd Cross section (Å2)e
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8 ADFTEISK albu_pig 910.00 219.61 (0.21) 3
8 AEFAEVSK HSA 879.97 214.97 (4.51) 2
8 AEFVEVTK BSA 922.05 223.42 1
8 AHELLNTK glox_aspgn 925.06 227.41 1
8 ALQASALK aldol_rab 800.96 218.92 (0.62) 3
8 DDHPNLPK albu_horse 935.01 211.02 (2.10) 3
8 DDNPNLPR HSA 939.99 218.41 (2.84) 2
8 DERFFSDK kcas_bov 1043.11 238.70 1
8 DIPVPKPK alcodehy_yst 893.10 219.20 (1.10) 3
8 DIVGAVLK alcodehy_yst 814.00 206.07 (0.54) 3
8 DLGEEHFK BSA 974.05 225.29 1
8 DLGEENFK HSA 951.01 223.98 (1.41) 3
8 DLGEQYFK albu_pig 999.10 232.22 (0.30) 3
8 DSADGFLK apotransf_bov 851.92 209.30 (1.09) 3
8 DSALGFLR lactotrans_bov 878.00 216.27 (4.91) 2
8 EALDFFAR alcodehy_yst 968.08 231.05 1
8 ELSDIAHR aldol_rab 940.03 221.32 (2.53) 3
8 EYEATLEK albu_dog 982.06 229.28 (0.93) 3
8 FGVNGSEK conalb_chick 836.91 201.76 (0.59) 3
8 GASIVEDK gludehy_bov 817.90 205.22 (1.78) 2
8 GFFYTPKA ins_bov 930.08 239.80 1
8 IDALNENK blacto_bov 916.01 225.09 (1.45) 3
8 IGDYAGIK alcodehy_yst 835.96 210.40 (0.63) 3
8 KLGLVGSR albu_pig 829.02 204.43 1
8 KVSEALTK hb_rab 875.04 213.55 (1.46) 3
8 LIVTQTMK blacto_bov 933.18 243.91 (0.71) 3
8 MVEGFFDR gludehy_bov 1000.14 237.35 (0.51) 3
8 RCQYVTEK aldol_rab 1026.18 244.74 (0.92) 2
8 SAASLNSR tryps 804.87 201.95 1
8 SEVAHRFK HSA 973.11 235.87 (1.31) 3
8 SHHWGYGK canhyd_bov 971.05 227.58 (0.33) 2
8 TKIPAVFK blacto_bov 903.14 227.74 (1.26) 3
8 TKLTEEEK acas_bov 977.09 243.22 1
8 TYETTLEK HSA 984.08 239.55 (1.30) 2
8 VHLSAEEK hb_pig 912.02 222.58 (1.10) 3
8 VHLTAEEK hb_dog 926.04 226.87 (0.45) 3
8 VHLTPEEK hb_hum 952.08 228.28 (2.05) 2
8 VLTPDLYK crephos_rab 948.13 230.73 (1.13) 2
8 VYGVQGLR glox_aspgn 891.05 218.35 (3.65) 2
8 YKELGFQG myo_horse 941.06 227.91 (0.59) 3
8 YLGEEYVK transfr_hum 1000.12 238.79 (1.26) 3
8 YNLGLDLR gludehy_bov 963.11 230.06 1
9 AAVTAFWGK hb_bov 950.11 237.76 (0.53) 4
9 AAVTGFWGK hb_sheep 936.09 233.00 (0.18) 3
9 ALMSAVEDR glox_aspgn 991.13 235.30 1
9 ANELLINVK alcodehy_yst 1013.21 249.69 (0.86) 3
9 APNHAVVTR transfr_hum 964.10 219.79 (0.94) 3
9 DFPIANGER canhyd_bov 1018.10 229.78 1
9 DGKYDLDFK enolase_yst 1100.20 250.07 (0.42) 2
9 DLLFRDDTK apotransf_bov 1122.25 248.68 1
9 EAVLGLWGK hb_pig 972.16 235.37 (1.14) 3
9 EGIPPDQQR ubiq 1039.12 229.87 1
9 ESTLHLVLR ubiq 1067.26 247.60 (3.52) 2
9 FMMFESQNK conalb_chick 1161.36 259.37 (4.27) 2
9 FQPLVDEPK albu_pig 1072.23 255.89 (0.74) 3
9 GNTHNVYAK glox_aspgn 1003.09 234.91 (0.68) 2
9 GTDVHAWIR lys_tew 1054.18 241.75 (0.34) 2
9 HGGFKPTDK crephos_rab 986.10 226.66 (0.55) 2
9 LDELRDEGK HSA 1074.16 233.18 1
9 LHVDPENFK hb_dog 1098.23 248.13 (1.98) 4
9 LHVDPENFR hb_hum 1126.24 246.51 (1.79) 4
hb_sheep
(Continued)
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9 LLGLFPDAN conA 959.12 232.59 (0.23) 3
9 LRVDPVNFK hb_bov 1087.29 250.74 (1.07) 2
hb_sheep
9 MFLGFPTTK hb_pig 1041.28 250.02 (1.45) 6
hb_pig
9 MFLSFPTTK hb_bov 1071.31 255.16 (0.70) 10
hb_hum
hb_sheep
9 QLLLTADDR aldol_rab 1044.18 246.37 (2.12) 2
9 QSALAELVK albu_horse 958.13 234.39 (1.35) 3
9 QTALVELLK albu_sheep 1014.24 245.01 (1.53) 3
9 QTALVELVK HSA 1000.21 242.43 (0.50) 3
9 RPAQPLKNR canhyd_bov 1079.30 254.31 (0.44) 2
9 SAVTALWGK hb_hum 932.09 231.09 (1.09) 6
hb_rab
9 SKGGVVGIK aldol_rab 844.03 211.01 (0.83) 2
9 SLVSGLWGK hb_dog 946.12 236.29 (0.69) 3
9 TDLNHENLK crephos_rab 1083.17 245.50 (0.58) 2
9 TFQSFPTTK hb_dog 1056.19 245.22 (0.25) 2
9 TGAPARSER enolase_yst 944.02 249.59 (3.78) 2
9 TLSDYNIQK ubiq 1081.20 248.81 1
9 VAAHAVVAR conalb_chick 893.06 228.54 (1.39) 3
9 YFGYTGALR conalb_chick 1047.19 238.95 (2.80) 2
9 YYGYTGAFR apotransf_bov 1097.20 242.91 (1.19) 2
10 AQSDFGVDTK conalb_chick 1067.13 241.43 (1.36) 3
10 DGAGDVAFVK transfr_hum 978.08 229.25 (0.61) 3
10 DLFDPIIQDR crephos_rab 1231.38 266.68 (0.41) 2
10 DSNVNWNNLK conalb_chick 1203.28 261.59 1
10 EAYKSEIAHR albu_dog 1203.33 267.64 (0.91) 3
10 ECCDKPLLEK BSA 1177.40 268.27 1
10 EKDIVGAVLK alcodehy_yst 1071.29 254.31 (1.07) 3
10 FKDLGEENFK HSA 1226.36 266.70 (2.94) 2
10 FKDLGEQYFK albu_pig 1274.45 269.57 (0.71) 2
10 GVIFYESHGK alcodehy_yst 1136.28 254.90 (0.56) 3
10 IGSEVYHNLK enolase_yst 1159.31 269.70 (0.37) 3
10 KQSALAELVK albu_horse 1086.30 255.37 (2.87) 3
10 KQTALVELLK albu_pig 1142.41 272.66 (2.62) 8
albu_sheep
BSA




10 LVASSQLALA albu_horse 972.16 234.24 (0.40) 3
10 LVASTQAALA albu_sheep 944.10 225.98 (0.62) 3
10 LVKELTEFAK albu_sheep 1177.41 265.20 (1.14) 3
10 LVNELTEFAK BSA 1163.34 267.51 (1.38) 3
10 LVNEVTEFAK albu_horse 1149.32 262.66 (0.85) 4
10 LVVSTQTALA BSA 1002.18 239.27 (1.48) 3
10 SEEEYPDLSK crephos_rab 1196.24 257.78 (0.49) 2
10 TAAYVNAIEK gludehy_bov 1079.23 246.52 (2.11) 2
10 VLDSFSNGMK hb_bov 1097.26 252.25 (1.41) 4
hb_sheep
10 VLNSFSDGLK hb_dog 1079.23 255.16 (0.96) 3
10 VLQSFSDGLK hb_pig 1093.25 255.95 (1.41) 3
10 YNDLGEEHFR albu_dog 1279.34 271.02 (1.40) 3
11 EMGGVVDNAAR glox_aspgn 1118.24 244.16 (0.66) 2
11 HKTDLNHENLK crephos_rab 1348.49 288.37 1
11 HLVDEPQNLIK albu_sheep 1305.50 282.63 (0.86) 5
BSA
11 HPDYSVSLLLR albu_horse 1299.50 296.03 (0.62) 3
11 HPEYAVSVLLR albu_sheep 1283.50 281.06 (2.47) 3
(Continued)
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11 KVLDSFSNGMK hb_bov 1225.43 266.78 (1.13) 4
hb_sheep
11 KVLQSFSDGLK hb_pig 1221.43 269.66 1
11 LEQWAEEAVAR glox_aspgn 1301.43 285.03 (2.29) 2
11 LFTGHPETLEK myo_horse 1271.44 277.00 1
11 LQHGTILGFPK gludehy_bov 1210.45 284.39 (0.59) 2
11 SASDLTWDNLK transfr_hum 1249.35 275.99 (2.94) 2
11 SCQAQPTTMAR kcas_bov 1193.40 260.11 (4.55) 2
11 SSGTSYPDVLK Tryps 1153.26 251.05 1
11 TGPNLHGLFGR cytc_horse 1168.33 257.73 1
11 TPEVDDEALEK blacto_bov 1245.31 249.83 (1.34) 3
11 VDEVGAEALGR hb_sheep 1115.22 251.98 (0.49) 3
11 VGLSASTGLYK conA 1095.27 270.04 (0.79) 3
11 VLSPADKTNIK hb_rab 1185.39 259.52 (2.72) 3
12 AAFTECCQAADK HSA 1257.41 271.68 1
12 EETLMEYLENPK cytc_horse 1495.67 309.03 1
12 EFTPVLQADFQK hb_bov 1422.61 305.06 (0.90) 4
12 FLANVSTVLTSK hb_rab 1279.51 297.19 (1.30) 5
hb_sheep
12 FLASVSTVLTSK hb_hum 1252.48 298.80 (0.41) 2
12 GQSIDDMIPAQK crephos_rab 1302.47 276.29 (2.26) 2
12 GTEFTVNDLQGK conalb_chick 1308.42 276.26 (0.93) 2
12 SIGGEVFIDFTK alcodehy_yst 1312.49 296.14 (0.34) 2
12 SISIVGSYVGNR alcodehy_yst 1251.41 267.82 (1.51) 3
12 TVDMESTEVFTK acas_bov 1386.54 304.91 1
12 TVLGNFSAFVAK albu_horse 1253.47 290.06 (1.14) 3
12 VNQIGTLSESIK enolase_yst 1288.47 278.77 (0.59) 3





13 GNPTVEVELTTEK enolase_yst 1416.56 302.96 (0.35) 2
13 LGEYGFQNALIVR albu_pig 1479.71 305.73 1
13 VKVDEVGAEALGR hb_sheep 1342.52 286.34 (1.24) 2
13 VKVDEVGGEALGR hb_bov 1328.50 281.42 (2.25) 2
13 VNVDEVGGEALGR hb_dog 1314.43 278.91 (1.10) 9
hb_hum
hb_pig
13 VNVEEVGGEALGR hb_rab 1328.45 278.43 (2.38) 2
14 APQVSTPTLVEIGR albu_horse 1467.69 305.13 1
14 GILAADESTGSIAK aldol_rab 1332.48 300.14 (0.72) 3
14 TAGWNIPMGLLYSK apotransf_bov 1550.84 323.84 1
14 TGQAPGFTYTDANK cytc_horse 1470.60 286.74 1
15 ANGTTVLVGMPAGAK alcodehy_yst 1386.64 286.04 (2.23) 2
15 AVDDFLISLDGTANK enolase_yst 1578.75 316.92 (2.52) 2
15 LGANAILGVSLAASR enolase_yst 1412.66 332.98 1
15 VGGNAGAYGAEALER hb_sheep 1434.54 287.23 (0.59) 2
15 VGGQAGAHGAEALER hb_pig 1422.53 284.89 (2.35) 2
aAll values were obtained using an injected-ion mobility/time-of-flight technique. For a description, see: Hoaglund, C. S.; Valentine, S. J.; Sporleder, C. R.;
Reilly, J. P.; Clemmer, D. E. Anal. Chem. 1998, 70, 2236; Henderson, S. C.; Valentine, S. J.; Counterman, A. E.; Clemmer, D. E. Anal. Chem. 1999, 71, 291.
bPeptide sequences correspond to fragments expected from tryptic digests as obtained from peptide_mass.pl (http://expasy.hcuge.ch/sprot/peptide-
mass.html). N-terminal acetylation is indicated by the prefix Ac.
cAll proteins were obtained from Sigma and used without further purification. Purities were typically $70%. Tryptic digests were performed by addition
of 150 mL of a 0.2-mg/mL trypsin (Sigma, sequencing grade) solution in 0.2 M ammonium bicarbonate (EM Science) to 0.5 mL of a 20-mg/mL solution
of each protein. Protein names are abbreviated as follows: albumin (albu), alcohol dehydrogenase (alcodehy), alpha-casein (acas), aldolase (aldol),
apotransferrin (apotransf), beta-casein (bcas), beta-lactoglobulin (blacto), bovine serum albumin (BSA), carbonic anhydrase (canhyd), conalbumin
(conalb), concanavalin A (conA), creatine phosphokinase (crephos), cytochrome c (cytc), glucose dehydrogenase (gludehy), glucose oxidase (glox),
hemoglobin (hb), human serum albumin (HSA), kappa-casein (kcas), lactotransferrin (lactotrans), lysozyme (lys), myoglobin (myo), transferrin
(transfr), and ubiquitin (ubiq). The sources of the proteins are separated from the protein name by an underscore, and are abbreviated as follows:
aspergillus niger (aspgn), bovine (bov), chicken (chick), human (hum), rabbit (rab), sperm whale (sw), turkey egg white (tew), and yeast (yst).
dMolecular weights are reported as an isotopic average and were checked by comparison with http://expasy.hcuge.ch/sprot/peptide-mass.html.
eCross sections correspond to the average of multiple data sets. Uncertainties are given in parentheses and correspond to one standard deviation
when three or more measurements were made, or as the range when only two measurements were made.
fTotal number of separate observations and cross section measurements for each peptide sequence.
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Number of
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4 IQDK ubiq 502.58 174.97 1
4 YTKK HSA 538.65 188.84 1
5 GITWK cytc_horse 603.70 172.82 1
5 IDAMR albu_sheep 604.73 205.17 (0.08) 2
5 IEHLR albu_pig 666.79 199.48 (1.23) 2
5 KNQDK kcas_bov 631.69 179.66 1
5 LRLQK crephos_rab 656.83 188.79 1
5 TLTGK ubiq 518.62 174.97 1
6 AKIQDK ubiq 701.83 212.99 1
6 AWSVAR albu_sheep 688.79 188.27 1
6 DWPDAR crephos_rab 758.80 208.84 1
6 FVIEIR albu_pig 775.95 211.25 1
6 GGVHVK crephos_rab 595.71 179.46 1
6 HLDDLK hb_bov 739.83 212.92 (1.16) 4
hb_sheep
6 HLDNLK hb_pig 738.85 212.80 (0.72) 3
6 IEEIFK crephos_rab 777.92 226.04 1
6 LIFAGK ubiq 647.83 199.02 1
6 LNQLLR enolase_yst 755.92 204.90 1
6 MQIFVK ubiq 764.99 222.87 1
6 QLEDGR ubiq 716.76 223.07 1
6 SEIAHR albu_pig 711.78 193.99 (2.55) 5
albu_sheep
6 YIPGTK cytc_horse 677.80 189.88 (3.56) 2
7 ASEDLKK myo_horse 789.89 238.09 1
7 ATDEQLK albu_sheep 803.87 205.29 1
7 ATKEQLK HSA 816.96 215.40 1
7 AVPYPQR bcas_bov 829.96 211.55 1
7 GDVAFVK transfr_hum 734.86 194.38 1
7 GFFYTPK ins_bov 859.00 225.36 1
7 GVLHAVK enolase_yst 722.89 202.50 1
7 IATAIEK enolase_yst 744.89 196.62 1
7 IVTDLAK albu_pig 758.92 201.59 (1.94) 2
7 LGLVGSR albu_pig 700.84 192.82 (2.40) 3
7 LMVEMEK crephos_rab 879.10 225.09 1
7 LVTDLTK BSA 788.95 210.68 1
7 MIFAGIK cytc_horse 779.00 207.03 (1.25) 3
7 NPDPWAK transfr_hum 826.91 213.72 1
7 Ac-SIPETQK alcodehy_yst 843.94 214.09 1




7 VKAHGKK hb_sheep 766.95 203.95 1
7 VLPVPQK bcas_bov 779.99 215.38 1
7 VVTDLTK albu_dog 774.92 205.05 1
7 WNMQNGK conA 876.99 211.48 (0.37) 2
7 YLYEIAR albu_pig 927.08 236.05 (0.46) 3
7 YLYEVAR albu_sheep 913.05 230.94 (0.30) 3
8 ADFAEISK albu_dog 879.97 213.59 1
8 ADFTDVTK albu_sheep 895.97 213.10 (1.15) 2
8 ADFTEISK albu_pig 910.00 219.23 1
8 DDHPNLPK albu_horse 935.01 225.23 1
8 DDNPNLPR HSA 939.99 229.08 1
8 DDTVCLAK transfr_hum 863.99 213.30 1
8 DIPVPKPK alcodehy_yst 893.10 231.34 1
8 DLGEENFK HSA 951.01 238.58 1
8 DLGEQYFK albu_pig 999.10 243.83 (0.55) 2
8 ELSDIAHR aldol_rab 940.03 232.56 (3.58) 2
8 EYEATLEK albu_dog 982.06 230.57 (2.63) 3
8 FGVNGSEK conalb_chick 836.91 211.12 (1.97) 3
8 IDALNENK blacto_bov 916.01 226.20 (1.73) 3
8 KLGLVGSR albu_pig 829.02 227.76 (0.13) 3
(Continued)
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8 KVSEALTK hb_rab 875.04 211.32 (0.42) 2
8 LIVTQTMK blacto_bov 933.18 234.72 1
8 SEVAHRFK HSA 973.11 231.57 1
8 VHLSAEEK hb_pig 912.02 226.77 (2.70) 3
8 VHLTAEEK hb_dog 926.04 230.04 (2.15) 2
8 VLTPDLYK crephos_rab 948.13 241.28 (2.73) 3
8 YLGEEYVK transfr_hum 1000.12 244.85 (4.55) 2
8 YLYEIARR HSA 1083.26 252.64 1
9 AAVTAFWGK hb_bov 950.11 229.12 (3.11) 3
9 AAVTGFWGK hb_sheep 936.09 229.67 1
9 ANELLINVK alcodehy_yst 1013.21 252.18 (2.33) 3
9 APNHAVVTR transfr_hum 964.10 231.13 (3.65) 3
9 EAVLGLWGK hb_pig 972.16 232.31 (0.88) 2
9 EGIPPDQQR ubiq 1039.12 252.51 1
9 EKVLASSAR albu_sheep 960.11 229.84 (0.42) 3
9 LHDRNTYEK transfr_hum 1175.27 261.21 (0.90) 2
9 LHVDPENFK hb_bov 1098.23 252.51 (3.57) 3
hb_dog
9 LHVDPENFR hb_hum 1126.24 255.74 (4.51) 2
hb_sheep
9 LRVDPVNFK hb_bov 1087.29 261.06 (3.73) 5
hb_hum
hb_sheep
9 MFLGFPTTK hb_pig 1041.28 248.32 (1.69) 5
hb_rab
9 MFLSFPTTK hb_bov 1071.31 254.66 (2.89) 8
hb_hum
hb_sheep
9 QLLLTADDR aldol_rab 1044.18 264.51 1
9 QSALAELVK albu_horse 958.13 238.41 1
9 QTALVELLK albu_sheep 1014.24 246.39 (2.50) 2
9 QTALVELVK HSA 1000.21 247.90 1
9 SAVTALWGK hb_hum 932.09 229.36 (1.54) 2
hb_rab
9 SKGGVVGIK aldol_rab 844.03 227.29 1
9 SLVSGLWGK hb_dog 946.12 236.87 1
9 TDLNHENLK crephos_rab 1083.17 258.47 (2.16) 3
9 TFQSFPTTK hb_dog 1056.19 244.10 (1.36) 2
9 TGAPARSER enolase_yst 944.02 239.16 1
9 TLSDYNIQK ubiq 1081.20 258.99 1
9 VAAHAVVAR conalb_chick 893.06 224.58 (2.42) 2
9 YFGYTGALR conalb_chick 1047.19 250.59 (4.81) 3
10 AWGGKKENLK aldol_rab 1130.32 265.36 1
10 DLFDPIIQDR crephos_rab 1231.38 275.32 (2.20) 3
10 EAYKSEIAHR albu_dog 1203.33 270.89 (0.00) 2
10 ECCEKPLLEK HSA 1191.43 267.09 1
10 EKDIVGAVLK alcodehy_yst 1071.29 253.92 (2.96) 3
10 FKDLGEEHFK BSA 1249.40 282.95 1
10 FKDLGEENFK HSA 1226.36 275.66 (0.71) 3
10 FKDLGEQYFK albu_pig 1274.45 286.80 (0.18) 3
10 GVIFYESHGK alcodehy_yst 1136.28 259.73 (2.27) 3
10 IGSEVYHNLK enolase_yst 1159.31 264.63 (1.78) 3
10 KQSALAELVK albu_horse 1086.30 252.69 1
10 KQTALVELLK albu_pig 1142.41 267.73 (2.24) 8
albu_sheep
BSA
10 KQTALVELVK HSA 1128.38 264.46 1
10 LLVVYPWTQR hb_hum 1274.54 287.97 (2.67) 4
hb_pig
hb_rab
10 LVNELTEFAK BSA 1163.34 266.65 1
10 LVNEVTEFAK albu_horse 1149.32 261.00 (1.56) 3
HSA
(Continued)
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10 SEEEYPDLSK crephos_rab 1196.24 261.41 (1.98) 2
10 VLNSFSDGLK hb_dog 1079.23 249.32 (0.48) 3
10 VLQSFSDGLK hb_pig 1093.25 255.01 (2.35) 3
10 YNDLGEEHFR albu_dog 1279.34 270.41 (0.71) 3
11 HKPHATEEQLR albu_pig 1345.49 284.51 (1.83) 3
11 HKTDLNHENLK crephos_rab 1348.49 295.16 1
11 HLVDEPQNLIK albu_sheep 1305.50 290.36 (0.83) 4
BSA
11 HPDYSVSLLLR albu_horse 1299.50 287.44 (0.31) 3
11 HPEYAVSVLLR albu_sheep 1283.50 287.75 (3.00) 2
11 HQTVPQNTGGK transfr_hum 1166.27 256.68 (4.86) 2
11 KVLDSFSNGMK hb_bov 1225.43 269.78 (4.85) 3
hb_sheep
11 KVLQSFSDGLK hb_pig 1221.43 290.65 1
11 LAKEYEATLEK albu_dog 1294.47 255.81 1
11 LEQWAEEAVAR glox_aspgn 1301.43 279.51 (3.87) 2
11 LFTGHPETLEK myo_horse 1271.44 286.20 (4.02) 2
11 SASDLTWDNLK transfr_hum 1249.35 277.98 1
11 SCQAQPTTMAR kcas_bov 1193.40 267.63 1
11 TGPNLHGLFGR cytc_horse 1168.33 267.56 (0.72) 3
11 TPEVDDEALEK blacto_bov 1245.31 269.64 (4.98) 2
11 VGLSASTGLYK conA 1095.27 253.96 (0.20) 2
11 VLSPADKTNIK hb_rab 1185.39 263.79 (2.50) 2
12 AAFTECCQAADK HSA 1257.41 269.89 (5.22) 2
12 AVMDDFAAFVEK HSA 1342.54 275.89 1
12 DTDFKLNELRGK apotransf_bov 1435.61 308.04 (0.23) 2
12 EETLMEYLENPK cytc_horse 1495.67 312.71 (0.80) 3
12 EFTPPVQAAYQK hb_hum 1378.55 289.31 (0.95) 2
12 EFTPVLQADFQK hb_bov 1422.61 300.31 (2.37) 4
12 ENLKAAQEEYVK aldol_rab 1421.58 308.18 1
12 FLANVSTVLTSK hb_rab 1279.51 287.78 (0.33) 3
hb_sheep
12 FLASVSTVLTSK hb_hum 1252.48 289.60 (2.14) 2
12 GQSIDDMIPAQK crephos_rab 1302.47 279.24 (2.24) 3
12 GTEFTVNDLQGK conalb_chick 1308.42 284.14 (1.72) 3
12 RHPEYAVSVLLR albu_sheep 1439.69 313.44 (2.35) 4
BSA
12 SIGGEVFIDFTK alcodehy_yst 1312.49 282.95 (4.08) 3
12 SISIVGSYVGNR alcodehy_yst 1251.41 278.59 (1.60) 2
12 TVDMESTEVFTK acas_bov 1386.54 294.42 (2.64) 2
12 TVLGNFSAFVAK albu_horse 1253.47 282.48 1
12 VNQIGTLSESIK enolase_yst 1288.47 278.95 1





12 VYGRCELAAAMK lys_tew 1311.59 283.85 1
13 CASIQKFGERALK BSA 1450.73 319.03 1
13 CLQDGAGDVAFVK lactotrans_bov 1322.51 284.08 1
13 FDKALKALPMHIR blacto_bov 1539.91 297.70 1
13 GNPTVEVELTTEK enolase_yst 1416.56 301.98 (2.86) 2
13 KGTEFTVNDLQGK conalb_chick 1436.59 298.50 (3.64) 3
13 KVYGRCELAAAMK lys_tew 1439.76 305.24 1
13 LGEYGFQNALIVR albu_pig 1479.71 313.94 (3.30) 2
BSA
13 RFYRQLLLTADDR aldol_rab 1666.91 325.91 1
13 SFLVWVNEEDHLR crephos_rab 1643.83 341.65 (2.24) 3
13 TCVADESHAGCEK BSA 1349.46 283.88 1
13 VKVDEVGAEALGR hb_sheep 1342.52 285.25 (0.03) 2
13 VKVDEVGGEALGR hb_bov 1328.50 285.58 (1.90) 4
(Continued)
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Table 2. (Continued)
Number
of residues Assigned sequenceb Peptide sourcec MWd Cross section (Å2)e
Number of
measurementsf
13 VNVDEVGGEALGR hb_dog 1314.43 287.12 (1.80) 7
hb_hum
hb_pig
13 VNVEEVGGEALGR hb_rab 1328.45 286.28 (3.03) 3
13 VVGLSTLPEIYEK alcodehy_yst 1447.70 310.43 (1.85) 2
14 APQVSTPTLVEIGR albu_horse 1467.69 306.85 (1.58) 2
14 GILAADESTGSIAK aldol_rab 1332.48 289.61 (3.75) 2
14 HGTVVLTALGGILK myo_horse 1378.79 312.22 (0.49) 3
14 LDELRDEGKASSAK HSA 1518.65 309.42 1
14 LSVEALNSLTGEFK crephos_rab 1507.71 318.15 (2.52) 3
14 SAGWNIPIGTLLHR conalb_chick 1534.79 315.82 1
14 TGQAPGFTYTDANK cytc_horse 1470.60 297.61 (2.24) 3
14 TPEVDDEALEKFDK blacto_bov 1635.75 333.91 (1.43) 2
14 VGTAHIIYNSVDKR conA 1572.79 343.52 (1.21) 3
14 VVAGVANALAHRYH hb_bov 1477.70 325.95 1
15 ANGTTVLVGMPAGAK alcodehy_yst 1386.64 302.28 1
15 AVDDFLISLDGTANK enolase_yst 1578.75 316.45 1
15 HQGLPQEVLNENLLR acas_bov 1759.99 353.86 1
15 IGGHAGDYGGEALDR hb_dog 1487.56 298.65 (0.89) 2
15 IGSHGGEYGAEAVER hb_rab 1531.61 299.00 (0.81) 2
15 KAPQVSTPTLVEIGR albu_horse 1595.87 330.12 (1.17) 2
15 KAPQVSTPTLVEISR albu_sheep 1625.89 331.49 (1.37) 3
15 LCMGSGLNLCEPNNK transfr_hum 1592.87 320.80 (0.05) 3
15 LGANAILGVSLAASR enolase_yst 1412.66 310.74 (6.42) 2
15 LGHDFNPNVQAAFQK hb_pig 1685.87 333.24 (0.91) 2
15 VEADIAGHGQEVLIR myo_horse 1606.81 340.95 (1.00) 3
15 VGAHAGEYGAEALER hb_hum 1529.64 306.47 (1.16) 2
15 VGGNAGAYGAEALER hb_sheep 1434.54 288.98 (1.80) 3
15 VGGQAGAHGAEALER hb_pig 1422.53 300.48 (2.81) 3
15 VLGIDGGEGKEELFR alcodehy_yst 1618.81 354.90 (1.40) 3
15 YSHEEIAMATVTALR aldol_rab 1691.93 335.42 (0.90) 3
16 GLSDGEWQQVLNVWGK myo_horse 1816.01 352.48 (0.52) 2
16 HGGTIPIVPTAEFQDR gludehy_bov 1737.94 335.66 1
16 HHGNEFTPVLQADFQK hb_sheep 1868.05 353.50 (1.14) 3
16 LLGNVLVCVLAHHFGK hb_hum 1720.12 318.03 1
16 NTDGSTDYGILQINSR lys_tew 1753.85 330.83 1
16 SISIVGSYVGNRADTR alcodehy_yst 1694.87 334.59 (1.85) 3
16 TITLEVEPSDTIENVK ubiq 1787.99 360.05 (0.47) 2
16 TYFPHFDFTHGSEQIK hb_rab 1954.14 363.50 (2.18) 3
16 TYFPHFDLSHGSAQVK hb_bov 1834.03 364.16 (1.49) 9
hb_hum
hb_sheep
16 TYFPHFDLSPGSAQVK hb_dog 1794.00 350.32 (1.56) 3
16 TYFPHFNLSHGSDQVK hb_pig 1877.05 369.15 1
16 VLAAFSEGLSHLDNLK hb_rab 1713.96 375.98 (3.62) 3
16 VLGAFSDGLAHLDNLK hb_hum 1669.91 365.62 (1.48) 2
16 WLTGPQLADLYHSLMK enolase_yst 1873.21 372.93 (1.77) 2
16 YLEFISDAIIHVLHSK myo_horse 1885.20 404.45 (0.04) 2
17 AAQDSFAAGWGVMVSHR enolase_yst 1789.99 371.96 (3.71) 2
17 GHHEAELKPLAQSHATK myo_horse 1854.06 361.52 1
17 HPYFYGPELLFHAEEYK albu_horse 2140.39 397.72 (1.79) 3
17 SGETEDTFIADLVVGLR enolase_yst 1822.01 354.32 (5.38) 2
17 STHETNALHFMFNQFSK conA 2039.26 384.39 (3.28) 3
17 TAGIQIVADDLTVTNPK enolase_yst 1755.99 357.02 1
18 AKIIAEGANGPTTPQADK gludehy_bov 1781.99 341.97 (4.73) 2
18 KGHHEAELKPLAQSHATK myo_horse 1982.24 374.41 1
18 MLTAEEKAAVTAFWGKVK hb_bov 1980.36 379.02 (4.54) 2
18 MLTAEEKAAVTGFWGKVK hb_sheep 1966.33 357.38 1
18 SIVPSGASTGVHEALEMR enolase_yst 1841.08 394.66 (1.36) 3
19 AHELLNTKLEQWAEEAVAR glox_aspgn 2208.47 390.65 1
19 DMPIQAFLLYQEPVLGPVR bcas_bov 2186.60 400.67 1
19 EPMIGVNQELAYFYPELFR acas_bov 2316.66 405.63 1
(Continued)
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bonate (EM Science) with 0.5 mL of a 20 mg/mL
solution of each protein. The digest solution is incu-
bated for 20 h at 37 °C and is filtered to remove trypsin
using a microconcentrator (microcon 10, Amicon, Inc.).
The remaining fragment peptides are lyophilized. Tryp-
tic digest solutions containing 0.5 mg/mL of the lyoph-
ilized product in 49:49:2 (% volume) water:acetonitrile:
acetic acid are electrosprayed to produce positively
charged (protonated) peptide ions. Solution flow rates
of 0.05–0.10 mL/h are utilized in these studies. Solu-
tions are electrosprayed at atmospheric pressure with a
needle that is biased at 13200 V relative to the entrance
of the desolvation region.
Ion Trap/Drift Tube Interface
Ions that exit the source are focused into an ion trap
(R. M. Jordan, model C-1251) [3, 5, 6], where they are
influenced by a 1.1-MHz rf field (2600 V peak to peak)
and collisions with residual gas molecules (1024 to 1023
torr). Here, the continuous beam is accumulated in a
small volume in the center of the trap that is aligned
with the entrance aperture of the drift tube. Ions are
ejected from the trap into the drift tube by turning off
the rf voltage and applying a 0.5 ms pulse (2100 to
2200 V) to the exit endcap. Injection voltages of 70 to
110 V were used. Cross section measurements over a
range of trapping potentials (from 1500 to 2600 V peak
to peak) and times (50 to 150 ms) are identical. Subse-
quent measurements of many cross sections have been
made using a high-pressure ion mobility instrument
that is suited for observation of fragile structure [28]; all
of the high pressure measurements agree with the
average values reported here to within the reported
uncertainty. We interpret the reproducibility of these
values over the range of conditions as an indication that
the values correspond to favorable gas-phase ion con-
formations rather than metastable states that are pre-
served during ESI, as has been observed for larger
protein systems [23c, 29–31].
Table 2. (Continued)
Number
of residues Assigned sequenceb Peptide sourcec MWd Cross section (Å2)e
Number of
measurementsf
19 FFDSFGDLSTPDAVMSNAK hb_dog 2049.25 385.30 (2.98) 2
19 FFEHFGDLSNADAVMNNPK hb_sheep 2153.36 393.23 (0.93) 3
19 FFESFGDLSNADAVMGNPK hb_pig 2046.25 377.85 (0.96) 2
19 FFESFGDLSSANAVMNNPK hb_rab 2075.29 381.63 (5.56) 3
19 FFESFGDLSTADAVMNNPK hb_bov 2090.30 388.79 (1.76) 4
19 FFESFGDLSTPDAVMGNPK hb_hum 2059.29 378.16 1
19 TVDYIIAGGGLTGLTTAAR glox_aspgn 1850.11 366.03 (2.52) 2
20 IGEHTPSALAIMENANVLAR aldol_rab 2107.42 399.25 2
20 VYVEELKPTPEGDLEILLQK blacto_bov 2313.68 426.75 (2.14) 2
21 AAANFFSASCVPCADQSSFPK apotransf_bov 2148.40 389.55 1
21 GTGGVDTAAVGSVFDISNADR crephos_rab 2009.12 363.68 (1.95) 2
22 AVEHLDDLPGALSELSDLHAHK hb_bov 2367.61 437.19 (2.50) 4
22 AVGHLDDLPGALSALSDLHAHK hb_pig 2237.51 418.64 (0.31) 2
22 AVGHLDDLPGALSTLSDLHAHK hb_rab 2267.53 422.37 (2.90) 2
22 AVGHLDDLPGTLSDLSDLHAHK hb_sheep 2311.54 438.43 (3.25) 3
22 RGTGGVDTAAVGSVFDISNADR crephos_rab 2165.31 387.93 (4.68) 2
22 TVGGKEDVIWELLNHAQEHFGK apotransf_bov 2507.80 432.00 1
22 YTPSGQAGAAASESLFISNHAY aldol_rab 2242.39 404.01 1
23 GVVPLAGTNGETTTQGLDGLSER aldol_rab 2272.46 396.30 (3.46) 3
23 WSGFSGGAIECETAENTEECIAK apotransf_bov 2432.62 412.48 1
24 ATDGGAHGVINVSVSEAAIEASTR alcodehy_yst 2312.49 415.18 (1.48) 3
24 NLCNIPCSALLSSDITASVNCAKK lys_tew 2465.89 412.61 1
aAll values were obtained using an injected-ion mobility/time-of-flight technique. For a description, see: Hoaglund, C. S.; Valentine, S. J.; Sporleder,
C. R.; Reilly, J. P.; Clemmer, D. E. Anal. Chem. 1998, 70, 2236; Henderson, S. C.; Valentine, S. J.; Counterman, A. E.; Clemmer, D. E. Anal. Chem. 1999,
71, 291.
bPeptide sequences correspond to fragments expected from tryptic digests as obtained from peptide-mass.pl (http://expasy.hcuge.ch/sprot/peptide-
mass.html). N-terminal acetylation is indicated by the prefix Ac.
cAll proteins were obtained from Sigma and used without further purification. Purities were typically $70%. Tryptic digests were performed by
addition of 150 mL of a 0.2-mg/mL trypsin (Sigma, sequencing grade) solution in 0.2 M ammonium bicarbonate (EM Science) to 0.5 mL of a 20-mg/mL
solution of each protein. Protein names are abbreviated as follows: albumin (albu), alcohol dehydrogenase (alcodehy), alpha-casein (acas), aldolase
(aldol), apotransferrin (apotransf), beta-casein (bcas), beta-lactoglobulin (blacto), bovine serum albumin (BSA), carbonic anhydrase (canhyd),
conalbumin (conalb), concanavalin A (conA), creatine phosphokinase (crephos), cytochrome c (cytc), glucose dehydrogenase (gludehy), glucose
oxidase (glox), hemoglobin (hb), human serum albumin (HSA), kappa-casein (kcas), lactotransferrin (lactotrans), lysozyme (lys), myoglobin (myo),
transferrin (transfr), and ubiquitin (ubiq). The sources of the proteins are separated from the protein name by an underscore, and are abbreviated
as follows: aspergillus niger (aspgn), bovine (bov), chicken (chick), human (hum), rabbit (rab), sperm whale (sw), turkey egg white (tew), and yeast
(yst).
dMolecular weights are reported as an isotopic average and were checked by comparison with http://expasy.hcuge.ch/sprot/peptide-mass.html.
eCross sections correspond to the average of multiple data sets. Uncertainties are given in parentheses and correspond to one standard deviation
when three or more measurements were made, or as the range when only two measurements were made.
fTotal number of separate observations and cross section measurements for each peptide sequence.
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Mass Spectrometer
Ions that exit the drift tube are focussed into the shape
of a ribbon using an einzel/dc-quadrupole lens system.
A four-grid system is used to extract ions into an
orthogonal TOF mass spectrometer. The field-free flight
tube is 17.5 cm long. Ions are detected by a pair of
microchannel plates mounted directly to the back of the
flight tube. High-frequency pulses (3 ms, 12220 V) are
supplied by a high-voltage pulser (Directed Energy Inc.,
model GRX-3.0K-H). Voltages in the time-of-flight in-
strument were determined from a space- and velocity-
focusing algorithm [32]. Typically the resolving power
(m/Dm) for singly-charged peptides is ;300.
Acquisition of Nested Drift(Flight) Time Data
Because flight times in the evacuated mass spectrometer
are much shorter than the drift times (in the high-
pressure drift tube) hundreds of mass spectra can be
recorded for each pulse of ions that is injected into the
drift tube. This is referred to as a “nested” drift(flight)
time measurement [5]. An initial pulse is used to inject
ions into the drift tube and simultaneously activate a
programmable delay generator (PDG, Lecroy 4222). The
PDG triggers the high-voltage TOF pulser at specified
delay times and a time-to-digital converter (TDC, Lec-
roy 4208) is used to record ion flight times. The initial
injection (drift) pulse, PDG pulse sequence, TDC, and
high-voltage TOF pulser are synchronized and under
computer control. Contour plots of the data were cre-
ated using the MATLAB software [33].
Experimental Collision Cross Sections
The arrival time of an ion at the detector is the sum of
its drift time, flight time, and the time required to travel
through interface regions of the instrument. To deter-
mine drift times it is necessary to account for the flight
time and a small correction associated with transport of
the ions from the exit of the drift tube to the entrance of
the time-of-flight region. Correction times are small (80
to 220 ms) compared with drift times (2 to 10 ms) in
these experiments. Experimental collision cross sections
(or collision integrals) [7] are obtained directly from the


















where tD, ED, L, P, and T correspond to the average
drift time, the drift electric field strength, the drift tube
length, buffer gas pressure (in torr) and temperature,
respectively. The other terms ze, N, kb, mI, and mB are
the charge of the ion, the neutral number density,
Boltzmann’s constant, and the masses of the ion and
buffer gas, respectively. Reproducibility of recorded
cross sections is high as noted by the small uncertainties
in Tables 1 and 2.
Drift times are determined from peak maxima in the
three-dimensional spectra, which are usually located in
the center of the peak. Most peaks can be accurately
represented by calculated peak shapes for single con-
formations obtained from the transport equation [4e,
34]. Although this is consistent with each peak corre-
sponding to single conformations, it is more likely that
related structures, which interconvert rapidly (com-
pared with experimental timescales) or have indistin-
guishable drift times, are present. Molecular dynamics
simulations for peptide ions at 300 K suggest that
peptides displaying compact conformations are com-
prised of rapidly interconverting (compared with the
millisecond experimental timescales) structures [35].
We currently believe that in most cases measured cross
sections correspond to a distribution of related states
centered about the favored conformers. Interconversion
of conformations over longer timescales would lead to
peak skewing. This is observed for some peptides, and
suggests that these peptides have conformations that
interconvert on a timescale similar to (or longer than)
the experimental timescale. For the peptides studied




Figure 1 shows a two-dimensional contour plot of the
nested drift(flight) times for a peptide mixture obtained
by electrospraying a tryptic digest of yeast enolase (mol.
wt. 5 46.7 kDa). A time-of-flight mass spectrum ob-
tained by compression of the drift axis is shown on the
left. Typically, peaks in the two-dimensional spectra for
tryptic digests fall into singly- ([M 1 H]1) and doubly-
([M 1 2H]21) charged families [5b]. The observation of
singly- and doubly-charged ions is expected because
trypsin cleaves peptide bonds on the C-terminal side of
basic residues [36]; this cleavage pattern results in the
generation of two protonatable sites (the N-terminus
and the C-terminal basic residue). Generally, for pep-
tides with similar m/z ratios, the [M 1 2H]21 ions have
higher mobilities (shorter drift times) than [M 1 H]1
ions because they experience twice the drift force. Solid
lines are used to distinguish the [M 1 H]1 and [M 1
2H]21 families in Figure 1. The combined mobility/TOF
approach allows rapid determination of the charge state
and reduces spectral congestion produced by the mul-
tiple-charging phenomenon of ESI. These advantages
facilitate peak identification.
Complete lists of singly and doubly charged pep-
tides identified in the digest spectra of the 34 proteins
are given in Tables 1 and 2, respectively. Only those
peptide sequences that have been unambiguously as-
signed have been included in this database. Average
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cross section, peptide molecular weight, protein digest
source, and the number of separate cross section mea-
surements for 420 singly charged peptides (containing 2
to 15 residues) and 240 doubly charged peptides (con-
taining 4 to 24 residues) are presented in these tables.
Most of the database peptides, 290 (11) and 164 (12),
contain a C-terminal lysine residue. Of the remaining
peptides, 114 (11) and 74 (12) contain a C-terminal
arginine residue. A significant percentage of these,
;12% (11) and ;25% (12), results from incomplete
tryptic digestion. Peptides containing cysteine residues
comprise only ;2% (11) and 6% (12) of the data.
For some tryptic digest systems, two-dimensional
spectra are extremely complicated. Figure 2 shows data
obtained upon ESI of tryptic fragments of human serum
albumin (mol. wt. 5 69.4 kDa). The [M 1 H]1 and
[M 1 2H]21 families are identified with solid lines;
however, at longer flight times (higher m/z), unresolved
features with mobilities that are higher than those
expected for [M 1 2H]21 family are observed. The
combined mobility-MS measurements suggest that
these features are associated with many unresolved 13
and higher charge state ions. Higher charge state ions
probably correspond to sequences with more than two
strongly basic (Arg, His, Lys, or N-terminal) residues.
Human serum albumin contains 17 disulfide linkages;
high-mobility, high m/z ions may correspond to disul-
fide-linked peptides or fragments that arise from in-
complete tryptic digestion. Partially solvated peptides
and aggregates may also contribute to the many unre-
solved peaks in this region; however, the experimental
conditions that were used favor formation of the naked
peptide monomer ions [9].
Cross Sections for Singly and Doubly Protonated
Peptide Ions
Figure 3a, b shows cross sections as a function of
molecular weight for the singly and doubly charged
database peptides, respectively. A strong correlation of
increasing cross section with increasing molecular
weight is observed; at similar molecular weights, cross
sections for different peptides vary by as much as
;10%–15%. In some regions, variations as large as 25%
Figure 1. A contour plot of “nested” drift time (bottom axis) and
flight time (left axis) data for the electrosprayed mixture of
peptide ions obtained from a tryptic digest of yeast enolase. The
drift time axis has been scaled to a He pressure of 2.000 torr. Two
distinct mobility families are observed; the higher and lower
mobility families have been determined to contain [M 1 2H]21
and [M 1 H]1 peptides, respectively. Labels have been assigned
to peaks that correspond with expected tryptic digest fragments
based on comparison of measured m/z ratios (from ion flight
times) to calculated molecular weights. In all cases the maximum
peak height is used to obtain a drift time from which collision
cross sections are derived. The time-of-flight distribution shown
on the left is obtained by compressing the drift time axis.
Figure 2. Contour plot of drift and flight times for a mixture of
peptides obtained from tryptic digestion of human serum albu-
min. Labels are shown for peaks that correspond to expected
tryptic digest fragments. Unresolved features arriving at longer
flight times and shorter drift times are believed to correspond to
multiply charged, disulfide-linked peptide fragments or multiply
charged peptide fragments resulting from incomplete tryptic
digestion. The time-of-flight distribution shown on the left is
obtained by compressing the drift time axis.
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are observed. In order to compare sizes of different
peptides it is useful to normalize cross section data with
respect to values obtained for a series of singly proto-
nated, polyalanine peptides containing 3 to 19 residues.
This removes the variations in cross section that occur
because of differences in mass. Polyalanine peptides
have roughly spherical (globular) conformations result-
ing from the self-solvation of the protonated N-terminal
amino group through interactions with electronegative
backbone carbonyl groups along the peptide chain [10b,
35]. We have previously defined reduced cross section
as the cross section of the database peptides divided by
the cross section of polyalanine at the same molecular
weight (provided by a polynomial fit to the polyalanine
data) [11]. Reduced cross sections for [XxxnLys 1 H]
1
(n 5 1–14) peptides are shown in Figure 4. Values
range from 0.96 to 1.18 (a range of ;25%) over the
molecular weight range studied. Reduced cross sections
for the majority (;96%) of the database peptides are
larger than 1.00, indicating that these peptides are
larger than polyalanine (for a given molecular weight).
Figure 3. (a) Cross sections for 420 [M 1 H]1 peptides (solid diamonds) as a function of molecular
weight. Uncertainties correspond to one standard deviation (when three or more measurements have
been made) or to a range (when only two values are available). The inset shows variations in cross
sections for [M 1 H]1 peptides over a smaller molecular weight range (defined by the dashed-line
box). (b) Cross section measurements for 240 [M 1 2H]21 peptides (open diamonds) as a function of
molecular weight.
Figure 4. Reduced cross sections and uncertainties for the
[(Xxx)nLys 1 H]
1 (Xxx represents any naturally occurring amino
acid and n 5 1–14) database peptides as a function of molecular
weight. The solid line corresponds to reduced cross sections for
peptides having the same cross section as the polyalanine data.
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High-density regions of points in this plot may indicate
preferred structural types; however, no assignable
trends have been determined.
Intrinsic Size Parameters
It is not feasible to measure cross sections for all
sequences of small peptides. Consider, for example,
five-residue tryptic fragments containing a C-terminal
arginine or lysine residue; there will be 320,000 [2(20)4]
different sequences. A method for accurate prediction
of cross sections would be valuable. From a series of
preliminary predictions of cross sections that were
carried out while the database was being compiled, we
determined that accurate predictions for peptide se-
quences that have not been measured require the de-
velopment of different parameterization sets from ho-
mologous peptides. A particularly important criterion
for a successful prediction based on sequence parame-
terization appears to be peptide length. In this section
we show several systems and examine their ability to
accurately predict cross sections for other peptides in
the database. A prediction is considered to be accurate
if it falls within 2% of the experimental values, because
this is often the level of accuracy reported for ion
mobility measurements of cross section [4e].
Table 3 lists four parameterization sets that have
been derived from the database. The first set was
obtained from the 113 [XxxnLys 1 H]
1 (n 5 4 –9) pep-
tides mentioned above [11] and is referred to as the
5-10-Lys parameter set. It is possible to calculate cross
sections that are within 2% of experimental values for
90% of the 113 peptides that were used to derive the
parameters [11]. Table 3 also gives parameters that were
derived from a series of 43 [XxxnLys 1 H]
1 peptides,
where n 5 8 –14 (the 9-15-Lys parameterization set).
Using these parameters, calculated cross sections for 33
of 43 peptides (;77%) are within 2% of experiment.
Another set of parameters was derived from a series of
81 [XxxnLys 1 H]
1 peptides, where n 5 2– 4. These
are referred to as the 3-5-Lys set. Fifty-eight of 81
peptides (;72%) are retrodicted to within 2% for these
parameters. Finally, parameters were derived from a
series of 41 [XxxnArg 1 H]
1 peptides, where n 5 4 –9
(the 5-10-Arg parameters); 38 of the 41 peptides (;93%)
are within 2% of experiment. The 5-10-Arg set is the
only parameterization set obtained from arginine-ter-
minated peptides because of the limited number of
these peptides. No parameter sets are presented for
peptides from incomplete digestion (where multiple
basic residues are present) because of small numbers of
related sequences.
One means of assessing the usefulness of intrinsic
size parameters for prediction of cross sections can be
obtained by comparing the retrodicted cross sections
with values determined by a polynomial fit of the cross
sections as a function of molecular weights. Figure 5a
shows the ratios of calculated to experimental cross
sections for singly-charged peptides over an extended
molecular weight range. In this figure, the cross sections
for peptides containing 2–4, 5–10, and 11–15 amino acid
residues were calculated using the 3-5-Lys, 5-10-Lys,
Table 3. Intrinsic size parameters for individual amino acid residuesa
Residue
Parameterization set
5-10-Lysb 9-15-Lysc 3-5-Lysd 5-10-Arge
Gly 0.99 (0.03) 0.95 (0.06) 1.11 (0.04) 0.99 (0.03)
Ala 1.08 (0.01) 1.05 (0.05) 1.11 (0.03) 1.04 (0.03)
Val 1.08 (0.02) 1.24 (0.08) 1.20 (0.08) 1.07 (0.05)
Ile 1.13 (0.04) 1.30 (0.15) 1.20 (0.07) 1.12 (0.05)
Leu 1.19 (0.02) 1.24 (0.05) 1.29 (0.04) 1.16 (0.02)
Met 1.04 (0.08) 1.04 (0.18) 1.07 (0.27) 1.07 (0.16)
Phe 1.05 (0.03) 1.29 (0.09) 1.14 (0.07) 0.97 (0.05)
Tyr 0.99 (0.07) 1.07 (0.36) 1.14 (0.12) 0.91 (0.03)
Trp 0.95 (0.12) 1.25 (0.35) 1.11 (0.16) 0.97 (0.41)
Ser 0.99 (0.04) 1.09 (0.06) 1.13 (0.08) 0.97 (0.04)
Thr 1.00 (0.02) 1.00 (0.04) 1.08 (0.05) 0.96 (0.07)
Asn 0.94 (0.04) 0.87 (0.11) 1.04 (0.06) 0.89 (0.08)
Asp 0.89 (0.03) 0.83 (0.07) 1.04 (0.09) 0.86 (0.04)
Gln 0.98 (0.07) 0.92 (0.13) 1.11 (0.20) 0.86 (0.05)
Glu 0.91 (0.02) 0.98 (0.06) 1.14 (0.07) 1.00 (0.05)
Pro 1.00 (0.05) 1.01 (0.14) 1.09 (0.10) 1.01 (0.06)
Lys 1.23 (0.04) 0.76 (0.27) 0.87 (0.04)
Arg 1.27 (0.07)
aThe amino acid size parameters were derived by solving a system of equations that relate the occurrence frequency of each amino acid and
unknown size parameters to a reduced cross section of each peptide (see text). Uncertainties, given parenthetically, correspond to one standard
deviation about the mean.
bAmino acid size parameters derived from 113 peptides having the form [XxxnLys 1 H]
1. Here, Xxx is any naturally occurring amino acid except Cys,
His, Lys, or Arg and n 5 4 to 9.
cAmino acid size parameters derived from 43 peptides having the form [XxxnLys 1 H]
1 (n 5 8 to 14).
dAmino acid size parameters derived from 81 peptides having the form [XxxnLys 1 H]
1 (n 5 2 to 4).
eAmino acid size parameters derived from 41 peptides having the form [XxxnArg 1 H]
1 (n 5 4 to 9).
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and 9-15-Lys parameterization sets, respectively (Table
3). Figure 5b shows a plot of the cross sections deter-
mined from a polynomial fit to the experimental values
divided by the individual cross sections; peptides of
different lengths (2–4, 5–10, and 11–15 residues) were
fit separately. The percentages of predicted cross sec-
tions within 2% of the experiment are ;70%, 90%, and
60% (for the parameterization models) and ;40%, 50%,
and 30% (for the polynomial fits) for peptides contain-
ing 2–4, 5–10, and 11–15 amino acid residues, respec-
tively. These results show that the parameterization
method significantly improves the accuracy of predic-
tion for a large fraction of the peptides.
It is instructive to assess the limits over which
predictions remain accurate. Figure 6a shows a plot of
cross sections that were calculated using the 5-10-Lys
parameters divided by experimental cross sections for
peptides containing 5–15 amino acid residues. The
percentage of successful predictions for 11–15 residue
peptides (which are not length homologues of the
peptides used to determine parameters) is much small-
er; ;40% are within 2% of experimental values. Figure
6b shows a ratio of calculated (5-10-Lys parameters) to
experimental cross sections for peptides containing 2–4
amino acid residues; ;70% of the four residue peptides
are predicted to within 2% of the corresponding exper-
imental values. Only ;15% of the three residue pep-
tides and none of the two residue peptides have calcu-
lated cross sections within 2% of the respective
experimental values. The 5-10-Lys parameterization set
overestimates the sizes of smaller peptides. Similar
studies tested the efficacy of the 9-15-Lys parameters in
predictions of [XxxnLys 1 H]
1 (n 5 1–7) peptides and
found that these parameters underestimate the experi-
mental cross sections; only ;25% of calculated values
were within 2% of the experimental values.
Bona Fide Cross Section Predictions
Extensive work involving sequence-to-structure predic-
tion methods in condensed phase have been carried out
Figure 5. (a) Plot of calculated cross sections divided by exper-
imental values as a function of molecular weight for [(Xxx)nLys 1
H]1 database peptides. Here Xxx refers to any naturally occurring
amino acid except Cys, His, Lys, or Arg and n 5 1–3 (open
diamonds), 4–9 (solid diamonds), and 10–14 (open diamonds)
amino acid residues. Cross sections for peptides containing 2–4,
5–10, and 11–15 amino acid residues were calculated using intrin-
sic size parameters obtained from the 3-5-Lys, 5-10-Lys, and
9-15-Lys sets (Table 3), respectively. (b) Plot of calculated cross
sections divided by experimental cross sections as a function of the
molecular weight for the same peptides shown in (a). The calcu-
lated cross sections were obtained from polynomial fits to the
cross section data over the different molecular weight ranges. In
both plots, dotted lines indicate the region where predicted values
agree to within 2% of experimental values.
Figure 6. (a) Plot of calculated cross sections divided by exper-
imental cross sections as a function of molecular weight for
[(Xxx)nLys 1 H]
1 peptide ions, where n 5 4 –9 (solid diamonds)
and n 5 10 –14 (open diamonds). (b) Plot of predicted cross
sections divided by experimental values as a function of molecular
weight for [(Xxx)nLys 1 H]
1 database peptides, where n 5 1
(open diamonds), n 5 2 (solid diamonds), and n 5 3 (open
diamonds). Size parameters from the 5-10-Lys parameterization
set (Table 3) were used for calculations. In both plots, dotted lines
indicate the region where predicted cross sections are found to be
within 2% of experimental values.
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[14, 26, 27]; it is often noted that the true test of methods
for predicting structure from sequence is to make the
prediction prior to the experimental measurement [14].
We have done this for 11 lysine-terminated peptides
containing 5–10 residues that are expected from tryptic
digestion of sperm whale myoglobin and yeast enolase
and have listed the predictions in Table 4. Only 10 of the
11 expected peptides were observed. Experimental
cross sections are also provided in Table 4 [37]. Consid-
ering the simplicity of this model, the agreement be-
tween these predictions and experiment is remarkable.
Eight predictions of the 10 peptides (80%) observed
experimentally are within 2% of experiment. All calcu-
lated cross sections are within 3.2% of the experimental
values. This is substantially better than predictions
based on a polynomial fit to cross section data, where
five are within 2% of experimental values, and five
deviate by more than 3.5%.
Variations in Size Parameters
It is clear that the chemical and physical properties of
amino acid residues influence ion cross section [11].
Peptide length, composition, and sequence should also
affect the types of gas-phase structures formed. The
parameterization sets described above were chosen to
represent peptides differing in composition and length.
The parameter sets show large changes in the size
parameter for lysine: 1.23 6 0.04 (5-10-Lys), 0.76 6 0.27
(9-15-Lys), 0.87 6 0.04 (3-5-Lys). When parameters for
other residues are examined, it appears that other
residues (within a parameter set) show smaller changes
that often appear to oppose the Lys contribution. For
example, comparison of the 5-10-Lys and 3-5-Lys pa-
rameter sets shows that in the latter set, the ;30%
decrease in the Lys parameter is accompanied by small
increases (3%–15%) in the other residues. Because the
Lys residue occurs in every sequence, it can mediate
changes that occur in all other parameters. In the
present system, the variation in the lysine size param-
eter has a pronounced influence on the ability of the
different parameter sets to predict accurate cross sec-
tions, especially for smaller peptides. This is expected
because the fraction of the prediction based on lysine
increases with decreasing number of peptide residues.
Additionally, one sees that if there are gross changes in
structure that occur over a small size range, the analysis
that we have presented will find only the best average
parameters; the interesting structural properties of out-
liers will be missed with this analysis. Clearly a larger
database where groups of deviating peptides are ob-
served will be useful for discerning structural proper-
ties.
Finally, we note that, overall, the trends in intrinsic
size parameters for different regions of the database are
similar to results that we obtained in our initial report
[11]. Table 3 shows that polar residues are smaller than
nonpolar residues for all of the parameterization sets
that were derived [11]. This is because the more attrac-
tive long-range interactions between polar groups lead
to more compact conformations. Additionally, for sev-
eral parameterization sets, the contributions to size
increase with increasing side chain length. This result
can be understood in terms of the larger number of
conformational degrees of freedom that are associated
with the longer sidechains.
Summary and Conclusions
The recent development of an ESI/ion trap/ion-mobil-
ity/time-of-flight mass spectrometry instrument [5a, 6]
has enabled measurements of cross sections for large












5 DIAAK myo_sw 516.60 155.37 (2.98) 156.63
5 TGQIK enolase_yst 545.64 157.92 (0.59) 158.60
6 AAAAEK enolase_yst 559.63 159.57 (1.96) 164.58
6 ANIDVK enolase_yst 658.76 178.62 (0.20) 177.84
6 ASEDLK myo_sw 661.72 175.16 (0.58) 177.37
6 NPNSDK enolase_yst 673.69 Not observed 171.03
6 TEAEMK myo_sw 707.80 181.27 (1.72) 186.57
6 NVPLYK enolase_yst 732.89 195.63 (0.22) 191.80
6 YDLDFK enolase_yst 799.89 198.72 (1.11) 201.58
7 IATAIEK enolase_yst 744.89 203.73 (0.67) 200.66
8 AADALLLK enolase_yst 814.00 221.35 (0.24) 218.01
aPeptide sequences correspond to fragments expected from tryptic digests as obtained from peptide-mass.pl (http://expasy.hcuge.ch/sprot/peptide-
mass.html). For cross section calculations, we have only included peptides of the general form [XxxnLys 1 H]
1 (Xxx corresponds to any naturally
occurring amino acid and n 5 4 to 14).
bMolecular weights are reported as isotopic averages.
cCross sections correspond to an average of three data sets. Uncertainties, given parenthetically, correspond to one standard deviation. One
sequence was not observed experimentally.
dReduced cross sections for each peptide were obtained using the 5-10-Lys parameterization set (Table 3) and eq 1. Calculated collision cross
sections were obtained by multiplying the reduced cross sections with a polynomial fit to the polyalanine cross sections as a function of molecular
weight (22.724 3 1025 x2 1 2.141 3 1021 x 1 4.080 3 101, where x 5 peptide molecular weight).
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numbers of peptide ions contained in mixtures. Data
from mixtures of peptides obtained upon digestion of
34 common proteins have been compiled into a struc-
tural database containing 660 entries (420 singly-
charged species and 240 doubly charged species). These
data have been used to determine intrinsic amino acid
size parameters which can be used to calculate cross
sections based solely on peptide composition for pep-
tides that have not been measured. The usefulness of
intrinsic size parameters for prediction of cross section
has been assessed by comparing predictions and exper-
imental values for different types of peptides using
different parameterization sets. Parameters for some
residues vary substantially for different peptide
lengths. Bona fide cross section predictions for a related
series of peptides are found to be reasonably accurate;
eight of 10 cross section predictions are within 2% of
experimental values and all 10 are within 3.2%. In the
absence of any experimental measurements, the tables
of amino acid size parameters for peptides containing
3–5, 5–10, and 9–15 residues should be valuable for
prediction of cross section. At this early stage, predicted
values should be used cautiously. These parameters
will be most useful for sequences that are similar to
those found in the proteins used in this study. Clearly,
sequences with specifically designed structures such as
helices or sheets may not be represented by this com-
position-based model; in these systems, sequence is also
an important structural factor. Initial molecular model-
ing studies of 103 of the [XxxnLys 1 H]
1 (n 5 4 – 8)
peptides show that most of these peptides have globu-
lar conformations where the charge is solvated by
electronegative groups [13]. A useful complement of
parameter-based predictions of cross sections would be
calculations of cross sections [8, 38, 39] for trial confor-
mations generated by molecular modeling [8a, 10, 40];
ultimately, parameter-based cross section predictions
may be a useful constraint in molecular modeling
strategies for calculating gas-phase ion structure. Stud-
ies of the general properties of the doubly charged ions
are currently underway in our laboratory.
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